๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Probiotic clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 2 trials in our China register that name Probiotic as an intervention. Synced 25 Sep 2026
2Current trials
1Recruiting now
2Lead sponsors
1Country register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards
At a glance

Probiotic is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Moon (Guangzhou) Biotechnology Co., Ltd (1). The most-studied condition is Anxiety Depression.

Trials by status

  • Recruiting150%
  • Not yet open150%

Trials by phase

  • Not applicable150%
  • Phase 2150%
01

Clinical trials of Probiotic

2 trials
StudyPhaseStatusLead sponsorRegisters
Efficacy and Safety of Probiotics for Anxiety Depression
NCT07331987 · ClinicalTrials.gov ↗ · Anxiety Depression
Not applicable Recruiting Moon (Guangzhou) Biotechnology Co., Ltd. China
Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC
NCT07474064 · ClinicalTrials.gov ↗ · Muscle Invasive Bladder Cancer (MIBC)
Phase 2 Not yet open chenxu China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Probiotic

2 conditions
Anxiety Depression1Muscle Invasive Bladder Cancer (MIBC)1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Moon (Guangzhou) Biotechnology Co., Ltd.1
chenxu1
04

By country register

RegisterTrialsRecruiting
Clinical trials in China21

A trial with sites in more than one country appears in each of those registers.

05

Related compounds

06

Questions about Probiotic trials

How many clinical trials are testing Probiotic?

2 current trials in our China register name Probiotic as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.

Are Probiotic trials recruiting patients?

Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Probiotic clinical trials?

Moon (Guangzhou) Biotechnology Co., Ltd (1) and chenxu (1). The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Probiotic works or whether it is effective, and it is not medical advice.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Probiotic works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Probiotic (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.